immunai
A Principal Scientist - Computational Biologist at Immunai develops innovative computational approaches to enhance the platform's value for industry partnerships and improve clinical trial success rates.
Headquarters
New York, New York, United States
Company Size
51-200 employees
Founded
2019
Immunai is a biotechnology company focused on decoding the immune system by mapping it at unprecedented scale and resolution to facilitate the development of next-generation immune-related therapeutics. The company partners with top biopharmaceutical companies and research institutions to support drug discovery and development through solutions including target discovery, preclinical evaluation, and clinical trial optimization. Its platform leverages multiomic data, a large harmonized single-cell immune database (AMICA), and advanced machine learning to deliver actionable insights for drug development strategies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for immunai.
27% above the average for this role
Computational Biology & Bioinformatics Scientist
ZIFO GmbH
Principal Scientist, Computational Biology
Bristol Myers Squibb
Senior Scientist I, Computational Biology
Sail Biomedicines
Senior Data Scientist/Computational Biologist
Harvard University
Computational Biology Scientist
GondolaBio Service Co, Inc.
Senior Scientist I, Computational Biology
Maze Therapeutics